why choose us

First received: November 9, 2022

Clinical Trial: Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction

Study Status: Completed

Recruit Status: Completed

Condition: Gut Microbiota
Intra-abdominal Infections
Acute Gastrointestinal Injury
Sepsis-associ

Study Type: Observational [Patient Registry]


Official Title: Gut Microbiota Analysis With Next-generation 16S rRNA Gene Sequencing in IAI Patients With Sepsis-associated Liver Dysfunction

Brief Summary: With the rapid development of intensive care medicine, the mortality of patients with sepsis has decreased over the past decade, but it is still the leading cause of death in intensive care unit (ICU). As an important immune and metabolic organ, the liver plays a crucial role in host defense against invading pathogens and endotoxins, as well as maintenance of metabolic and immunological homeostasis. Some studies indicate that sepsis-associated liver dysfunction (SALD) has a substantial impact on the severity and…

Read more